Elborn, J. S., Ramsey, B. W., Boyle, M. P., Konstan, M. W., Huang, X., Marigowda, G., . . . Wainwright, C. E. (2016). Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup. Lancet Respir Med.
Styl ChicagoElborn, J. Stuart, Bonnie W. Ramsey, Michael P. Boyle, Michael W. Konstan, Xiaohong Huang, Gautham Marigowda, David Waltz, a Claire E. Wainwright. "Efficacy and Safety of Lumacaftor/ivacaftor Combination Therapy in Patients With Cystic Fibrosis Homozygous for Phe508del CFTR By Pulmonary Function Subgroup." Lancet Respir Med 2016.
Citace podle MLAElborn, J. Stuart, et al. "Efficacy and Safety of Lumacaftor/ivacaftor Combination Therapy in Patients With Cystic Fibrosis Homozygous for Phe508del CFTR By Pulmonary Function Subgroup." Lancet Respir Med 2016.